Yuviwel
- Product NDC
- 73362-201
- 11-digit product format
- 733620201
- Labeler code
- 73362
- Product ID
- 73362-201_7bc0f18a-5736-4451-8790-f3780b742ab3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Navepegritide
- Dosage form
- KIT
- Labeler
- Ascendis Pharma Endocrinology, Inc.
- Application
- NDA219164
- Marketing category
- NDA
- Marketing start
- 2026-02-27
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Yuviwel
- Listing expiration
- 2027-12-31
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Rxcui | 2739524, 2739529, 2739531, 2739533, 2739535, 2739537 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73362-201-01 | Yuviwel | 4 in 1 CARTON | KIT | 4 | | 4 |
| 73362-201-02 | Yuviwel | 1 in 1 BOX | KIT | 1 | | 4 |
| 73362-205-01 | Yuviwel | 1 in 1 VIAL, GLASS | INJECTION, POWDER, LYOPHILIZED, | 1 | 1.3 mg | 4 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 73362-201-01 | 73362020101 | 4 BOX in 1 CARTON (73362-201-01) / 1 KIT in 1 BOX (73362-201-02) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (73362-205-01) * 1 SOLUTION in 1 SYRINGE, GLASS (73362-801-01) | 4 box | 2026-02-27 | No | No | Current |
| 73362-201-02 | 73362020102 | 1 in 1 BOX | | | | | Historical |
| 73362-205-01 | 73362020501 | 1 in 1 VIAL, GLASS | | | | | Historical |